JACQUELINE LOIACONO: Open Payments
NPI 1992401335 · ELGIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,017 in 33 payments from 13 companies in 2025. Trend: 2023 $225 · 2024 $948 · 2025 $1,017
Food & beverage: $968Education: $49
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $288 |
| Actelion Pharmaceuticals US, Inc. | 2 | $119 |
| Novo Nordisk Inc | 1 | $117 |
| Novartis Pharmaceuticals Corporation | 3 | $85 |
| HEARTFLOW, INC. | 4 | $81 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $58 |
| Esperion Therapeutics, Inc. | 2 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Edwards Lifesciences Corporation | 1 | $36 |
Products named: REPATHA, Ozempic, LEQVIO, FFRct, UPTRAVI, LifeVest, NEXLETOL, ELIQUIS.
Industry payments across IL — which companies pay providers there.
